Cellyan Biotechnology Co (HKPD) Stock Price
Cellyan Biotechnology Co Price
Over the last 3 years Cellyan Biotechnology Co grew revenue by 2.0% annually, reaching 13.30 M USD. For Cellyan Biotechnology Co, the net margin of -8.5% is down versus 8.0% a few years ago.
Cellyan Biotechnology Co stock price
Cellyan Biotechnology Co business model & stock analysis
Frequently asked questions about Cellyan Biotechnology Co
Converted at the current exchange rate, the Cellyan Biotechnology Co share trades at 0.10 EUR (0.11 USD).
The revenue of Cellyan Biotechnology Co is 13.30 M USD. This figure is based on current financial data and reflects the company's business performance.
The profit of Cellyan Biotechnology Co is -1.14 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cellyan Biotechnology Co is currently -3.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cellyan Biotechnology Co stock.
The price-to-sales ratio (P/S) of Cellyan Biotechnology Co is currently 0.30. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cellyan Biotechnology Co stock.
The Eulerpool Quality Score for Cellyan Biotechnology Co is 1/10.
The ISIN of Cellyan Biotechnology Co is KYG6365B1041. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Cellyan Biotechnology Co is HKPD. The ticker symbol is used to trade Cellyan Biotechnology Co shares on the stock exchange.
Cellyan Biotechnology Co stock
Cellyan Biotechnology Co Peer Group
All fundamentals and in-depth analysis of Cellyan Biotechnology Co
Our stock analysis for Cellyan Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellyan Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.